Identifying patient subgroups to improve outcome, resistance and toxicity in CAR T

Identifying patient subgroups to improve outcome, resistance and toxicity in CAR T

VJHemOnc

1 year
179 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
CAR T-cells have the potential to revolutionize the field of hematological oncology, however despite impressive efficacy data from CAR T products, some patients develop resistance, have poor outcomes, or high toxicity. As John Rossi, MS, from Kite Pharma Inc., Santa Monica, CA explains in this video, identifying the characteristics of these patients is crucial to informing treatment planning for specific patient groups. He discusses how identifying patients at risk of toxicity can mean high-risk patients are placed under surveillance, while low-risk individuals are able to receive therapy on an outpatient basis. He highlights how features of the tumor microenvironment and immune landscape might predict treatment outcome, and how understanding the specific features of the CAR T product can further improve identification of poor outcome patients. This type of research is crucial to improving clinical disease management and CAR T-cell therapy outcomes.
Up Next Autoplay
Lower Costs for Patients in Metastatic Breast Cancer
Lower Costs for Patients in Metastatic Breast Cancer
Category: Breast Cancer
3 Views
ONeal Comprehensive Cancer Center 1 day
New Technology to Streamline Drug Discovery
New Technology to Streamline Drug Discovery
Category: Other
3 Views
Cancer-News 2 days
Using Technology to Better Understand What Goes Wrong in Cancer
Using Technology to Better Understand What Goes Wrong in Cancer
Category: Breast Cancer
1 Views
Cancer-News 2 days
How Does This Affect Clinicians Today?
How Does This Affect Clinicians Today?
Category: Breast Cancer
2 Views
Cancer-News 2 days
Measuring Chromatin Accessibility: How Reliable is This Data?
Measuring Chromatin Accessibility: How Reliable is This Data?
Category: Breast Cancer
1 Views
Cancer-News 2 days
Dual-function Virus Designed For Killing Tumor Cells and Helping Immune Cells
Dual-function Virus Designed For Killing Tumor Cells and Helping Immune Cells
Category: Melanoma and Skin Cancer
5 Views
Cancer-News 2 days
Mapping the usual breast development to recognize cancer better
Mapping the usual breast development to recognize cancer better
Category: Breast Cancer
6 Views
Cancer-News 2 days
Metformin: How Does This Affect Treatment?
Metformin: How Does This Affect Treatment?
Category: Ovarian Cancer
6 Views
Cancer-News 2 days
New Frontier Possibility for Preventing Ovarian Cancer
New Frontier Possibility for Preventing Ovarian Cancer
Category: Ovarian Cancer
3 Views
Cancer-News 2 days
"Wild idea" opens possible new boundaries to ovarian cancer prevention
Category: Ovarian Cancer
5 Views
Cancer-News 2 days